Twist Bioscience Cash from Financing (Quarterly) Analysis

Twist Bioscience Corp (TWST)

41.21 +9.20 (+28.74%) USD | NASDAQ | May 03, 16:00

41.18 -0.03 (-0.07%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	1.828M
December 31, 2023	-1.473M
September 30, 2023	0.442M
June 30, 2023	-0.661M
March 31, 2023	1.525M
December 31, 2022	-0.395M
September 30, 2022	1.24M
June 30, 2022	-1.311M
March 31, 2022	271.62M
December 31, 2021	-1.011M
September 30, 2021	1.575M
June 30, 2021	-0.765M
March 31, 2021	1.451M

Date	Value
December 31, 2020	326.92M
September 30, 2020	5.574M
June 30, 2020	108.06M
March 31, 2020	188.04M
December 31, 2019	2.057M
September 30, 2019	2.928M
June 30, 2019	84.28M
March 31, 2019	-1.634M
December 31, 2018	73.00M
September 30, 2018	6.583M
June 30, 2018	24.83M
March 31, 2018	54.75M
December 31, 2017	2.662M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-1.473M

Minimum

Dec 2023

326.92M

Maximum

Dec 2020

49.60M

Average

1.55M

Median

Cash from Financing (Quarterly) Benchmarks

Tandem Diabetes Care Inc	2.617M
Perspective Therapeutics Inc	0.352M
Xtant Medical Holdings Inc	0.325M
Asensus Surgical Inc	0.172M
Catheter Precision Inc	-0.107M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-19.42M
Cash from Investing (Quarterly)	-5.24M
Free Cash Flow	-95.52M
Free Cash Flow Per Share (Quarterly)	-0.3466
Free Cash Flow to Equity (Quarterly)	-20.03M
Free Cash Flow to Firm (Quarterly)	-20.03M
Free Cash Flow Yield	-4.04%